Reference architecture · DRS 1.4 · WES independently versioned

GA4GH DRS + WES Deployment Pattern

Maintained by Global Alliance for Genomics and Health

What it helps you do

Use DRS + WES when you need composable APIs for identifying and retrieving data, submitting workflows, and enabling federated genomic analysis.

  • Omics
  • Clinical
PlanAcquireHarmonizeExchangeLearn + reuse

01

Where it fits—and where it doesn’t

Use these four checks before committing implementation time.

Use it when
Cloud and federated genomics where data access and computation must work across heterogeneous repositories.
Do not use it as
Do not treat DRS + WES as a complete solution on its own. The APIs solve infrastructure interoperability, not dataset semantics, consent harmonization, or analytical comparability on their own.
Best for
Teams working with Omics and Clinical data across Exchange → Learn + reuse.
Maturity
ScalingUsable today, with adoption or tooling still scaling; pilot the exact stack you plan to run.

02

See it in the workflow

A standard creates value by changing a handoff, not by existing in a catalog.

  1. InputWhat starts

    Omics and Clinical data, metadata, and the local decisions around them

  2. DRS + WESWhat changes

    DRS + WES applies a shared reference architecture across Exchange → Learn + reuse

  3. OutputWhat becomes possible

    A more consistent, reviewable handoff for the next system or team

Readiness gateBefore scaling: The APIs solve infrastructure interoperability, not dataset semantics, consent harmonization, or analytical comparability on their own.

03

A concrete example

A research platform resolves a controlled genomic object through DRS, then runs a portable workflow through WES near the data.

Why it matters: Enables governed compute-to-data and repeatable access paths for large omics assets; feature semantics remain external.

04

What it fits with

DRS resolves logical data IDs; WES submits and monitors workflows; deployments pair the APIs with authorization and domain formats.

05

Implementation starter

Start with one bounded handoff. Pin, test, and review it before scaling.

  1. Name an accountable owner and the decision DRS + WES must support.

  2. Pin the exact version and companion artifacts: DRS 1.4 · WES independently versioned.

  3. Map one representative input to the required reference architecture artifacts.

  4. Test the result against the canonical source and record every exception.

  5. Preserve the source data, mappings, and review evidence before scaling.

06

Limitation to test first—and the tests that catch it

Risk

The APIs solve infrastructure interoperability, not dataset semantics, consent harmonization, or analytical comparability on their own.

Test

Run one representative end-to-end pilot and record exactly where DRS + WES loses context, needs an extension, or depends on another standard.

Risk

A structured or machine-readable result can still be unfit for analysis or AI.

Test

Test the output for missing context, provenance, terminology alignment, time leakage, and the intended downstream decision. Enables governed compute-to-data and repeatable access paths for large omics assets; feature semantics remain external.

07

Why we believe this

Checked against the canonical source plus independent operational evidence from an adopter, regulator, or implementation report.

Evidence notation: E1 + E2. The code is shorthand; the plain-language statement above is the claim.

Formal status
Current GA4GH APIs; versions independent
Confidence
High
Review state
Source-checked
Reviewed by
Federated genomics reviewer
Last verified
13 July 2026
Review again when
DRS, WES, access, or implementation update
How the evidence method works

08

Source shelf

Official diagrams, examples, specifications, and explainers. Nothing external loads until you choose to open it.

  • Primary sourceDRS 1.4 · WES independently versioned

    GA4GH Data Repository Service

    The canonical publisher or steward source used to verify this reference architecture profile.

    Publisher
    Global Alliance for Genomics and Health
    Rights
    Rights remain with the publisher; this knowledge base links to the source rather than copying it.
    Access
    Opens the publisher's source in a new tab; no external media loads on this page.
    Verified
    2026-07-13
    Open at source

Next action

Put this profile in context

Compare its role with adjacent standards or place it inside an end-to-end data pathway before choosing an implementation.